Referências:
1. Health, N.I.o. Phenylketonuria: screening and management. 2000 [cited June 2011; Available from: http://consensus.nih.gov/2000/2000Phenylketonuria113html.htm.
2. Camp, K.M., et al., Phenylketonuria Scientific Review Conference: state of the science and future research needs. Mol Genet Metab, 2014. 112(2): p. 87-122.
3. Christ, S.E., et al., Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab, 2010. 99 Suppl 1: p. S22- 32.
4. Dobrowolski, S.F., et al., Altered DNA methylation in PAH deficient phenylketonuria. Mol Genet Metab, 2015. 115(2-3): p. 72-7.
5. Hoeksma, M., et al., Phenylketonuria: High plasma phenylalanine decreases cerebral protein synthesis. Mol Genet Metab, 2009. 96(4): p. 177-82.
6. Bilder DA, Burton BK, Coon H, Leviton L, Ashworth J, Lundy BD, et al. Psychiatric symptoms in adults with phenylketonuria. Molecular Genetics & Metabolism 2013;108(3):155-60.
7. Burton BK, Leviton L, Vespa H, CoonH, Longo N, Lundy BD, et al. A diversified approach for PKU treatment: routine screening yields high incidence of psychiatric distress in phenylketonuria clinics. Molecular Genetics & Metabolism 2013;108(1):8-12.
8. Agostoni C, Harvie A, McCulloch DL, Demellweek C, Cockburn F, Giovannini M, et al. A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev Med Child Neurol 2006;48(3):207-12.
9. Koch, R., F. Trefz, and S. Waisbren, Psychosocial issues and outcomes in maternal PKU. Mol Genet Metab, 2010. 99 Suppl 1: p. S68-74.
10. Levy, H.L., et al., Congenital heart disease in maternal phenylketonuria: report from the Maternal PKU Collaborative Study. Pediatr Res, 2001. 49(5): p. 636-42.
11. Protocolo Clínico e Diretrizes Terapêuticas Fenilcetonúria, Portaria SAS/MS no. 1.307- 22 de novembro de 2013.
12. Osmo HG, Silva IW, R. F. Fenilcetonúria: da restrição dietética à inclusão socioeconômica. Phenylketonuria: from the dietary restriction to social-economic inclusion. Rev Bras Nutr Clin. 2008:104-10.
13. Yu JS. Phenylketonuria: a review. Postgrad Med J. 197 0;46(537):430-6.
14. Campistol Plana J, Alvarez Dominguez L, Riverola de Veciana AT, Castillo Rivera P, P. GS. Hiperfenilalaninemia y fenilcetonuria. Interés del diagnóstico precoz y seguimiento de la enfermedad en un centro de referecial1991:[51-6 pp.].
15. MacDonald, A., van Wegberg, A.M.J., Ahring, K. et al. PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis 15, 171 (2020).https://doi.org/10.1186/s13023-020-01391-y.
16. Phenylketonuria. Blau N, van Spronsen FJ, Levy HL. Lancet. 2010 Oct 23;376(9750):1417-27. doi: 10.1016/S0140-6736(10)60961-0.
17. CONITEC – Relatório de Recomendação-Protocolo Clínico e Diretrizes Terapêuticas Fenilcetonúria de março de 2019.
18. Gambol PJ. Maternal phenylketonuria syndrome and case management implications. J Pediatr Nurs. 2007;22(2):129-38.
19. Van Wegberg AMJ, MacDonal A, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, et al. The complete european guidelines to phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017Oct 12;12(1):162.
20. Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, et al. Phenylketonuria Scientific Review Conference: state of the science and future research needs. Mol Genet Metab. 2014 Jun;112(2):87-122.
21. Güttler F. Phenylketonuria: 50 years since Følling’s discovery and still expanding our clinical and biochemical knowledge. Acta Paediatr Scand. 1984;73(6):705-16.
22. De Carvalho TM, Dos Santos HP, Dos Santos IC, Vargas PR, Pedrosa J. Newborn screening: a national public health programme in Brazil. J Inherit Metab Dis. 2007 Aug;30(4):615. Epub 2007 Aug 10.
23. Triagem Neonatal Biológica: Manual Técnico. Brasília – DF. 2016.
